Treating NPC cells with calycosin (20–50 μM) showed a decreased expression of ESWAT1, p‐TAK1, p‐IкB, and p‐c‐Jun and suppression of NPC cells by mediating downstream effectors TRAF6 and TAK‐1.92 This evidence concerns the gene ATP8A2 and nasopharyngeal carcinoma.